Over time, molecular biology and genomics techniques have been developed to speed up
the early diagnosis and clinical management of cancer. These therapies are often most
effective when administered to the subset of malignancies harboring the target identified by
molecular testing. Important advances in applying molecular testing involve circulating-free
DNA (cf DNA)-and cell-free RNA (cf RNA)-based liquid biopsies for the diagnosis,
prognosis, prediction, and treatment of cancer. Both cf DNA and cf RNA are sensitive and …

Over time, molecular biology and genomics techniques have been developed to speed up
the early diagnosis and clinical management of cancer. These therapies are often most
effective when administered to the subset of malignancies harboring the target identified by
molecular testing. Important advances in applying molecular testing involve circulating-free
DNA (cfDNA)-and cellfree RNA (cfRNA)-based liquid biopsies for the diagnosis, prognosis,
prediction, and treatment of cancer. Both cfDNA and cfRNA are sensitive and specific …